MTIP
FLXN

Magee Thomson Investment Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Magee Thomson Investment Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1K Sell
33
-37
-53% -$755 ﹤0.01% 76
2016
Q4 		$1K Buy
+70
New +$1.34K ﹤0.01% 80

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Magee Thomson Investment Partners's FLXN Position: Q1 2017 in Review

Magee Thomson Investment Partners reduced its Flexion Therapeutics, Inc. (FLXN) stake by 53% in Q1 2017, selling an estimated $755 and leaving 33 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #76.

Magee Thomson Investment Partners first reported a position in FLXN in Q4 2016 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold FLXN as of Q1 2017.

  • Magee Thomson Investment Partners held 33 shares of Flexion Therapeutics, Inc. worth $1K as of Q1 2017.
  • Magee Thomson Investment Partners sold 37 Flexion Therapeutics, Inc. shares in Q1 2017, an estimated $755.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #76 holding.
  • Magee Thomson Investment Partners first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and has held it in 2 quarters since.
  • 100 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.